Quibim is making its QP-Prostate software available to healthcare organizations in North America through Microsoft’s Precision Imaging Network, a platform that provides access to third-party imaging AI applications.
QP-Prostate automatically detects and identifies suspected lesions on bi-parametric prostate MRI and marks them as an overlay on the source images, according to the vendor. The software is cleared by the U.S. Food and Drug Administration (FDA) and holds a class III medical device license from Health Canada.
Precision Imaging Network routes imaging studies to the applications an organization has selected using existing image-sharing infrastructure, according to the firm. In supported configurations, QP-Prostate results can be delivered to Microsoft’s PowerScribe reporting software, where radiologists can review and incorporate them before finalizing reports, Quibim said.
